Sakar Healthcare Ltd.
•₹ 912.63.16%
2026-08-21
PROS
- Latest quarter profit grew 120.2% YoY, showing strong momentum
- Company has delivered good sales growth of 16.4% CAGR over last 5 years
- Strong cash generation - operating cash flow backs reported profits (CFO/PAT 2.19x)
- Operating margins have improved to 28.2% from 24.6%
- Company maintains a comfortable, low leverage position
CONS
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of 8.3%
- Company has a low return on equity of 6.8% over last 3 years
- Equity base is being diluted - shares outstanding up 28.2%
- Inventory has been piling up - inventory days up from 51 to 73
- Expensive relative to growth - PEG of 5.6
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1898.00 | 37.65 | 455393.78 | 0.84 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8525.00 | 77.37 | 226311.96 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 5013.00 | 87.43 | 190678.41 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1416.00 | 33.94 | 114392.01 | 0.92 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1105.00 | 24.42 | 110224.17 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2220.00 | 18.36 | 101506.15 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2391.00 | 48.34 | 98747.34 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1171.00 | 30.33 | 97740.54 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1807.00 | 89.30 | 97634.42 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1615.15 | 25.03 | 92932.16 | 0.25 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 414.30 | 136.32 | 67518.23 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SAKAR | 871.00 | 53.69 | 1937.97 | 0.00 | 102.85 | 2101.88 | 729.72 | 1283.72 | 8.43 | 29.12 |
Detailed Comparison with:
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39 | 34 | 37 | 43 | 41 | 43 | 43 | 50 | 53 | 58 | 70 | 71 | 73 | |
| 30 | 25 | 28 | 32 | 30 | 31 | 32 | 35 | 40 | 46 | 52 | 45 | 60 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 2 |
| Interest | 2 | 2 | 2 | 2 | 1 | 2 | 1 | 4 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 5 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 7 |
| 4 | 4 | 3 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 11 | 18 | 15 | |
| Tax % | 28.10% | 12.53% | 31.00% | 34.79% | 48.72% | 6.26% | 17.15% | 7.69% | 13.17% | 15.30% | 6.39% | 38.98% | 29.47% |
| Net Profit | 3 | 4 | 2 | 3 | 2 | 5 | 5 | 6 | 5 | 5 | 10 | 11 | 10 |
| 1 | 2 | 1 | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 5 | 5 | 0 | |
| Equity Capital | 19 | 21 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 19 | 21 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 39
- 30
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 2
- Depreciation
- 5
- 4
- Tax %
- 28.10%
- Net Profit
- 3
- 1
- Equity Capital
- 19
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 19
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 34
- 25
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 4
- 4
- Tax %
- 12.53%
- Net Profit
- 4
- 2
- Equity Capital
- 21
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 21
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 37
- 28
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 4
- 3
- Tax %
- 31.00%
- Net Profit
- 2
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 43
- 32
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 5
- 5
- Tax %
- 34.79%
- Net Profit
- 3
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 41
- 30
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 5
- 5
- Tax %
- 48.72%
- Net Profit
- 2
- 1
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 43
- 31
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 5
- 5
- Tax %
- 6.26%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 43
- 32
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 1
- Depreciation
- 5
- 5
- Tax %
- 17.15%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 50
- 35
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 4
- Depreciation
- 5
- 6
- Tax %
- 7.69%
- Net Profit
- 6
- 3
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 53
- 40
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 6
- 5
- Tax %
- 13.17%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 58
- 46
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 6
- 5
- Tax %
- 15.30%
- Net Profit
- 5
- 2
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 70
- 52
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 2
- Depreciation
- 6
- 11
- Tax %
- 6.39%
- Net Profit
- 10
- 5
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 71
- 45
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 2
- Depreciation
- 6
- 18
- Tax %
- 38.98%
- Net Profit
- 11
- 5
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 73
- 60
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 2
- Depreciation
- 7
- 15
- Tax %
- 29.47%
- Net Profit
- 10
- 0
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 22
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 41 | 44 | 53 | 68 | 83 | 95 | 128 | 133 | 153 | 178 | 272 | |
| 33 | 34 | 41 | 51 | 63 | 72 | 99 | 100 | 115 | 128 | 203 | |
| Operating Profit | 9 | 11 | 13 | 18 | 22 | 24 | 32 | 38 | 42 | 51 | — |
| OPM % | 21 | 25 | 25 | 26 | 26 | 25 | 25 | 28 | 27 | 29 | — |
| Other Income | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 5 | 3 | 1 | 3 |
| Interest | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 6 | 8 | 9 | 7 |
| Depreciation | 3 | 3 | 4 | 6 | 7 | 8 | 10 | 15 | 18 | 21 | 25 |
| 3 | 5 | 6 | 9 | 12 | 13 | 19 | 17 | 16 | 22 | 49 | |
| Tax % | 19 | 30 | 38 | 28 | 21 | 19 | 20 | 25 | 27 | 20 | 26 |
| Net Profit | 2 | 3 | 4 | 7 | 10 | 11 | 15 | 13 | 12 | 18 | 36 |
| EPS | 0 | 0 | 0 | 0 | 0 | 7 | 10 | 7 | 5 | 8 | — |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 3 | 3 | 4 | 6 | 7 | 9 | 7 | 5 | 8 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 3 | 3 | 3 | 4 | 6 | 7 | 9 | 7 | 5 | 8 | — |
Mar 2016
- 41
- 33
- Operating Profit
- 9
- OPM %
- 21
- Other Income
- 0
- Interest
- 3
- Depreciation
- 3
- 3
- Tax %
- 19
- Net Profit
- 2
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2017
- 44
- 34
- Operating Profit
- 11
- OPM %
- 25
- Other Income
- 1
- Interest
- 3
- Depreciation
- 3
- 5
- Tax %
- 30
- Net Profit
- 3
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2018
- 53
- 41
- Operating Profit
- 13
- OPM %
- 25
- Other Income
- 1
- Interest
- 3
- Depreciation
- 4
- 6
- Tax %
- 38
- Net Profit
- 4
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 3
Mar 2019
- 68
- 51
- Operating Profit
- 18
- OPM %
- 26
- Other Income
- 1
- Interest
- 2
- Depreciation
- 6
- 9
- Tax %
- 28
- Net Profit
- 7
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 4
Mar 2020
- 83
- 63
- Operating Profit
- 22
- OPM %
- 26
- Other Income
- 2
- Interest
- 2
- Depreciation
- 7
- 12
- Tax %
- 21
- Net Profit
- 10
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 6
Mar 2021
- 95
- 72
- Operating Profit
- 24
- OPM %
- 25
- Other Income
- 1
- Interest
- 2
- Depreciation
- 8
- 13
- Tax %
- 19
- Net Profit
- 11
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2022
- 128
- 99
- Operating Profit
- 32
- OPM %
- 25
- Other Income
- 2
- Interest
- 3
- Depreciation
- 10
- 19
- Tax %
- 20
- Net Profit
- 15
- EPS
- 10
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 9
Mar 2023
- 133
- 100
- Operating Profit
- 38
- OPM %
- 28
- Other Income
- 5
- Interest
- 6
- Depreciation
- 15
- 17
- Tax %
- 25
- Net Profit
- 13
- EPS
- 7
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 7
Mar 2024
- 153
- 115
- Operating Profit
- 42
- OPM %
- 27
- Other Income
- 3
- Interest
- 8
- Depreciation
- 18
- 16
- Tax %
- 27
- Net Profit
- 12
- EPS
- 5
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 5
Mar 2025
- 178
- 128
- Operating Profit
- 51
- OPM %
- 29
- Other Income
- 1
- Interest
- 9
- Depreciation
- 21
- 22
- Tax %
- 20
- Net Profit
- 18
- EPS
- 8
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 8
TTM
- 272
- 203
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 7
- Depreciation
- 25
- 49
- Tax %
- 26
- Net Profit
- 36
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- 18%
- 5 Years:
- 16%
- 3 Years:
- 11%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- 25%
- 5 Years:
- 13%
- 3 Years:
- 5%
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- 40%
- 3 Years:
- 39%
- 1 Year:
- 176%
RETURN ON EQUITY
- 10 Years:
- 11%
- 5 Years:
- 9%
- 3 Years:
- 7%
- Last Year:
- 6%
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - | - | - |
| Equity Capital | 8 | 11 | 12 | 15 | 15 | 16 | 17 | 19 | 22 | 22 |
| 9 | 25 | 35 | 57 | 66 | 83 | 110 | 154 | 236 | 261 | |
| 4 | 5 | 1 | 3 | 2 | 2 | 5 | 13 | 14 | 21 | |
| Trade Payables | 4 | 3 | 4 | 4 | 5 | 20 | 31 | 26 | 27 | 21 |
| 26 | 27 | 29 | 19 | 26 | 58 | 105 | 124 | 90 | 90 | |
| Total Liabilities | 51 | 71 | 81 | 97 | 115 | 178 | 268 | 336 | 389 | 415 |
| ASSETS | - | - | - | - | - | - | - | - | - | - |
| 37 | 49 | 53 | 64 | 66 | 69 | 205 | 267 | 314 | 309 | |
| Capital Work in Progress | 0 | 0 | 0 | 9 | 13 | 49 | 1 | 6 | 0 | 17 |
| 0 | 0 | 0 | 0 | 0 | 0 | 7 | 3 | 0 | 0 | |
| 6 | 7 | 4 | 7 | 11 | 16 | 14 | 15 | 28 | 44 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21 | 31 | |
| 7 | 14 | 23 | 18 | 25 | 44 | 41 | 44 | 25 | 15 | |
| Total Assets | 51 | 71 | 81 | 97 | 115 | 178 | 268 | 336 | 389 | 415 |
| Total Debt | 19 | 21 | 15 | 11 | 17 | 43 | 93 | 119 | 79 | 86 |
| Net Working Capital | 1 | 8 | 15 | 6 | 7 | 1 | 3 | 1 | 13 | 26 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 21.45 | 32.39 | 38.34 | 47.95 | 54.35 | 63.04 | 74.50 | 91.09 | 118.44 | 128.78 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 19 | 21 | 15 | 11 | 17 | 43 | 93 | 119 | 79 | 86 |
| Net Working Capital | 1 | 8 | 15 | 6 | 7 | 1 | 3 | 1 | 13 | 26 |
| Contingent Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book Value per Share | 21.45 | 32.39 | 38.34 | 47.95 | 54.35 | 63.04 | 74.50 | 91.09 | 118.44 | 128.78 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2016
- Equity Capital
- 8
- 9
- 4
- Trade Payables
- 4
- 26
- Total Liabilities
- 51
- 37
- Capital Work in Progress
- 0
- 0
- 6
- 0
- 7
- Total Assets
- 51
- Total Debt
- 19
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 21.45
- Face Value
- 10.00
- Total Debt
- 19
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 21.45
- Face Value
- 10.00
Mar 2017
- Equity Capital
- 11
- 25
- 5
- Trade Payables
- 3
- 27
- Total Liabilities
- 71
- 49
- Capital Work in Progress
- 0
- 0
- 7
- 0
- 14
- Total Assets
- 71
- Total Debt
- 21
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 32.39
- Face Value
- 10.00
- Total Debt
- 21
- Net Working Capital
- 8
- Contingent Liabilities
- 0
- Book Value per Share
- 32.39
- Face Value
- 10.00
Mar 2018
- Equity Capital
- 12
- 35
- 1
- Trade Payables
- 4
- 29
- Total Liabilities
- 81
- 53
- Capital Work in Progress
- 0
- 0
- 4
- 0
- 23
- Total Assets
- 81
- Total Debt
- 15
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 38.34
- Face Value
- 10.00
- Total Debt
- 15
- Net Working Capital
- 15
- Contingent Liabilities
- 0
- Book Value per Share
- 38.34
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 15
- 57
- 3
- Trade Payables
- 4
- 19
- Total Liabilities
- 97
- 64
- Capital Work in Progress
- 9
- 0
- 7
- 0
- 18
- Total Assets
- 97
- Total Debt
- 11
- Net Working Capital
- 6
- Contingent Liabilities
- 0
- Book Value per Share
- 47.95
- Face Value
- 10.00
- Total Debt
- 11
- Net Working Capital
- 6
- Contingent Liabilities
- 0
- Book Value per Share
- 47.95
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 15
- 66
- 2
- Trade Payables
- 5
- 26
- Total Liabilities
- 115
- 66
- Capital Work in Progress
- 13
- 0
- 11
- 0
- 25
- Total Assets
- 115
- Total Debt
- 17
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 54.35
- Face Value
- 10.00
- Total Debt
- 17
- Net Working Capital
- 7
- Contingent Liabilities
- 0
- Book Value per Share
- 54.35
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 16
- 83
- 2
- Trade Payables
- 20
- 58
- Total Liabilities
- 178
- 69
- Capital Work in Progress
- 49
- 0
- 16
- 0
- 44
- Total Assets
- 178
- Total Debt
- 43
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 63.04
- Face Value
- 10.00
- Total Debt
- 43
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 63.04
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 17
- 110
- 5
- Trade Payables
- 31
- 105
- Total Liabilities
- 268
- 205
- Capital Work in Progress
- 1
- 7
- 14
- 0
- 41
- Total Assets
- 268
- Total Debt
- 93
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 74.50
- Face Value
- 10.00
- Total Debt
- 93
- Net Working Capital
- 3
- Contingent Liabilities
- 0
- Book Value per Share
- 74.50
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 19
- 154
- 13
- Trade Payables
- 26
- 124
- Total Liabilities
- 336
- 267
- Capital Work in Progress
- 6
- 3
- 15
- 0
- 44
- Total Assets
- 336
- Total Debt
- 119
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 91.09
- Face Value
- 10.00
- Total Debt
- 119
- Net Working Capital
- 1
- Contingent Liabilities
- 0
- Book Value per Share
- 91.09
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 22
- 236
- 14
- Trade Payables
- 27
- 90
- Total Liabilities
- 389
- 314
- Capital Work in Progress
- 0
- 0
- 28
- 21
- 25
- Total Assets
- 389
- Total Debt
- 79
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 118.44
- Face Value
- 10.00
- Total Debt
- 79
- Net Working Capital
- 13
- Contingent Liabilities
- 0
- Book Value per Share
- 118.44
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 22
- 261
- 21
- Trade Payables
- 21
- 90
- Total Liabilities
- 415
- 309
- Capital Work in Progress
- 17
- 0
- 44
- 31
- 15
- Total Assets
- 415
- Total Debt
- 86
- Net Working Capital
- 26
- Contingent Liabilities
- 0
- Book Value per Share
- 128.78
- Face Value
- 10.00
- Total Debt
- 86
- Net Working Capital
- 26
- Contingent Liabilities
- 0
- Book Value per Share
- 128.78
- Face Value
- 10.00
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 | 9 | 5 | 16 | 19 | 15 | 36 | 33 | 24 | 34 | |
| Cash from Investing | -4 | -4 | -8 | -25 | -22 | -47 | -90 | -74 | -52 | -31 |
| Cash from Financing | -6 | -6 | -13 | 9 | 3 | 32 | 55 | 41 | 27 | -3 |
| -1 | -1 | -16 | 0 | -0 | -0 | -0 | 0 | 0 | -0 | |
| Free Cash Flow | 5 | -6 | -4 | 14 | 5 | -33 | -62 | -41 | -35 | 2 |
| OCF / Net Profit | 3.95 | 2.72 | 1.38 | 2.41 | 1.95 | 1.36 | 2.35 | 2.61 | 2.10 | 1.94 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 15 | -23 | -78 | -116 | -166 | -169 |
| OCF / Net Profit | 3.95 | 2.72 | 1.38 | 2.41 | 1.95 | 1.36 | 2.35 | 2.61 | 2.10 | 1.94 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 15 | -23 | -78 | -116 | -166 | -169 |
Mar 2016
- 9
- Cash from Investing
- -4
- Cash from Financing
- -6
- -1
- Free Cash Flow
- 5
- OCF / Net Profit
- 3.95
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 3.95
- Cumulative 5-Year FCF
- 0
Mar 2017
- 9
- Cash from Investing
- -4
- Cash from Financing
- -6
- -1
- Free Cash Flow
- -6
- OCF / Net Profit
- 2.72
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.72
- Cumulative 5-Year FCF
- 0
Mar 2018
- 5
- Cash from Investing
- -8
- Cash from Financing
- -13
- -16
- Free Cash Flow
- -4
- OCF / Net Profit
- 1.38
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 1.38
- Cumulative 5-Year FCF
- 0
Mar 2019
- 16
- Cash from Investing
- -25
- Cash from Financing
- 9
- 0
- Free Cash Flow
- 14
- OCF / Net Profit
- 2.41
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.41
- Cumulative 5-Year FCF
- 0
Mar 2020
- 19
- Cash from Investing
- -22
- Cash from Financing
- 3
- -0
- Free Cash Flow
- 5
- OCF / Net Profit
- 1.95
- Cumulative 5-Year FCF
- 15
- OCF / Net Profit
- 1.95
- Cumulative 5-Year FCF
- 15
Mar 2021
- 15
- Cash from Investing
- -47
- Cash from Financing
- 32
- -0
- Free Cash Flow
- -33
- OCF / Net Profit
- 1.36
- Cumulative 5-Year FCF
- -23
- OCF / Net Profit
- 1.36
- Cumulative 5-Year FCF
- -23
Mar 2022
- 36
- Cash from Investing
- -90
- Cash from Financing
- 55
- -0
- Free Cash Flow
- -62
- OCF / Net Profit
- 2.35
- Cumulative 5-Year FCF
- -78
- OCF / Net Profit
- 2.35
- Cumulative 5-Year FCF
- -78
Mar 2023
- 33
- Cash from Investing
- -74
- Cash from Financing
- 41
- 0
- Free Cash Flow
- -41
- OCF / Net Profit
- 2.61
- Cumulative 5-Year FCF
- -116
- OCF / Net Profit
- 2.61
- Cumulative 5-Year FCF
- -116
Mar 2024
- 24
- Cash from Investing
- -52
- Cash from Financing
- 27
- 0
- Free Cash Flow
- -35
- OCF / Net Profit
- 2.10
- Cumulative 5-Year FCF
- -166
- OCF / Net Profit
- 2.10
- Cumulative 5-Year FCF
- -166
Mar 2025
- 34
- Cash from Investing
- -31
- Cash from Financing
- -3
- -0
- Free Cash Flow
- 2
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- -169
- OCF / Net Profit
- 1.94
- Cumulative 5-Year FCF
- -169
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - | - | - |
| EPS (₹) | 2.91 | 3.08 | 3.12 | 4.47 | 6.43 | 6.85 | 8.90 | 6.70 | 5.37 | 7.97 |
| Book Value (₹) | 21.45 | 32.39 | 38.34 | 47.95 | 54.35 | 63.04 | 74.50 | 91.09 | 118.44 | 128.78 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 6.33 | 6.17 | 6.73 | 8.51 | 11.16 | 12.01 | 14.55 | 14.57 | 13.66 | 17.49 |
| PROFITABILITY | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 20.74% | 24.67% | 24.69% | 25.71% | 25.99% | 25.12% | 24.63% | 28.45% | 25.03% | 28.18% |
| Net Margin % | 5.65% | 7.65% | 7.19% | 9.81% | 11.60% | 11.29% | 11.89% | 9.57% | 7.61% | 9.86% |
| ROE % | 14.56% | 12.83% | 9.27% | 11.29% | 12.57% | 11.89% | 13.49% | 8.48% | 5.42% | 6.48% |
| ROCE % | 15.29% | 16.11% | 14.17% | 15.45% | 16.02% | 13.16% | 12.13% | 8.95% | 7.41% | 8.52% |
| 4.60% | 5.55% | 5.03% | 7.50% | 9.06% | 7.30% | 6.84% | 4.22% | 3.22% | 4.35% | |
| EFFICIENCY | - | - | - | - | - | - | - | - | - | - |
| Debtor Days | 22 | 34 | 56 | 54 | 39 | 40 | 38 | 50 | 51 | 53 |
| Inventory Days | 58 | 55 | 37 | 29 | 39 | 51 | 43 | 40 | 51 | 73 |
| Payable Days | 41 | 58 | 49 | 43 | 40 | 90 | 123 | 140 | 117 | 108 |
| 39 | 32 | 44 | 40 | 38 | 1 | -43 | -50 | -14 | 19 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 1.13x | 0.60x | 0.31x | 0.15x | 0.21x | 0.43x | 0.73x | 0.69x | 0.31x | 0.31x |
| Interest Coverage (x) | 1.98x | 2.79x | 3.36x | 5.07x | 6.41x | 6.31x | 7.53x | 3.85x | 3.09x | 3.56x |
| 1.11x | 1.67x | 2.14x | 1.44x | 1.52x | 1.02x | 1.07x | 1.03x | 1.21x | 1.41x | |
| GROWTH | - | - | - | - | - | - | - | - | - | - |
| Revenue Growth % | 17.70% | 7.14% | 20.16% | 28.59% | 21.58% | 14.17% | 35.35% | 4.00% | 14.99% | 15.80% |
| Operating Profit Growth % | 8.27% | 27.44% | 20.27% | 33.87% | 22.92% | 10.34% | 32.74% | 20.12% | 9.56% | 23.55% |
| Net Profit Growth % | 26.78% | 45.10% | 12.92% | 75.45% | 43.78% | 11.11% | 42.56% | -16.30% | -8.53% | 49.96% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -19.92% | 48.59% | |
| VALUATION | - | - | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 68.64x | 26.55x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3.11x | 1.64x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 21.17x | 10.73x |
Mar 2016
- EPS (₹)
- 2.91
- Book Value (₹)
- 21.45
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.33
- Operating Margin %
- 20.74%
- Net Margin %
- 5.65%
- ROE %
- 14.56%
- ROCE %
- 15.29%
- 4.60%
- Debtor Days
- 22
- Inventory Days
- 58
- Payable Days
- 41
- 39
- Debt to Equity (x)
- 1.13x
- Interest Coverage (x)
- 1.98x
- 1.11x
- Revenue Growth %
- 17.70%
- Operating Profit Growth %
- 8.27%
- Net Profit Growth %
- 26.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2017
- EPS (₹)
- 3.08
- Book Value (₹)
- 32.39
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.17
- Operating Margin %
- 24.67%
- Net Margin %
- 7.65%
- ROE %
- 12.83%
- ROCE %
- 16.11%
- 5.55%
- Debtor Days
- 34
- Inventory Days
- 55
- Payable Days
- 58
- 32
- Debt to Equity (x)
- 0.60x
- Interest Coverage (x)
- 2.79x
- 1.67x
- Revenue Growth %
- 7.14%
- Operating Profit Growth %
- 27.44%
- Net Profit Growth %
- 45.10%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2018
- EPS (₹)
- 3.12
- Book Value (₹)
- 38.34
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 6.73
- Operating Margin %
- 24.69%
- Net Margin %
- 7.19%
- ROE %
- 9.27%
- ROCE %
- 14.17%
- 5.03%
- Debtor Days
- 56
- Inventory Days
- 37
- Payable Days
- 49
- 44
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 3.36x
- 2.14x
- Revenue Growth %
- 20.16%
- Operating Profit Growth %
- 20.27%
- Net Profit Growth %
- 12.92%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 4.47
- Book Value (₹)
- 47.95
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 8.51
- Operating Margin %
- 25.71%
- Net Margin %
- 9.81%
- ROE %
- 11.29%
- ROCE %
- 15.45%
- 7.50%
- Debtor Days
- 54
- Inventory Days
- 29
- Payable Days
- 43
- 40
- Debt to Equity (x)
- 0.15x
- Interest Coverage (x)
- 5.07x
- 1.44x
- Revenue Growth %
- 28.59%
- Operating Profit Growth %
- 33.87%
- Net Profit Growth %
- 75.45%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2020
- EPS (₹)
- 6.43
- Book Value (₹)
- 54.35
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 11.16
- Operating Margin %
- 25.99%
- Net Margin %
- 11.60%
- ROE %
- 12.57%
- ROCE %
- 16.02%
- 9.06%
- Debtor Days
- 39
- Inventory Days
- 39
- Payable Days
- 40
- 38
- Debt to Equity (x)
- 0.21x
- Interest Coverage (x)
- 6.41x
- 1.52x
- Revenue Growth %
- 21.58%
- Operating Profit Growth %
- 22.92%
- Net Profit Growth %
- 43.78%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 6.85
- Book Value (₹)
- 63.04
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 12.01
- Operating Margin %
- 25.12%
- Net Margin %
- 11.29%
- ROE %
- 11.89%
- ROCE %
- 13.16%
- 7.30%
- Debtor Days
- 40
- Inventory Days
- 51
- Payable Days
- 90
- 1
- Debt to Equity (x)
- 0.43x
- Interest Coverage (x)
- 6.31x
- 1.02x
- Revenue Growth %
- 14.17%
- Operating Profit Growth %
- 10.34%
- Net Profit Growth %
- 11.11%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- 8.90
- Book Value (₹)
- 74.50
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.55
- Operating Margin %
- 24.63%
- Net Margin %
- 11.89%
- ROE %
- 13.49%
- ROCE %
- 12.13%
- 6.84%
- Debtor Days
- 38
- Inventory Days
- 43
- Payable Days
- 123
- -43
- Debt to Equity (x)
- 0.73x
- Interest Coverage (x)
- 7.53x
- 1.07x
- Revenue Growth %
- 35.35%
- Operating Profit Growth %
- 32.74%
- Net Profit Growth %
- 42.56%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- 6.70
- Book Value (₹)
- 91.09
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.57
- Operating Margin %
- 28.45%
- Net Margin %
- 9.57%
- ROE %
- 8.48%
- ROCE %
- 8.95%
- 4.22%
- Debtor Days
- 50
- Inventory Days
- 40
- Payable Days
- 140
- -50
- Debt to Equity (x)
- 0.69x
- Interest Coverage (x)
- 3.85x
- 1.03x
- Revenue Growth %
- 4.00%
- Operating Profit Growth %
- 20.12%
- Net Profit Growth %
- -16.30%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- 5.37
- Book Value (₹)
- 118.44
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.66
- Operating Margin %
- 25.03%
- Net Margin %
- 7.61%
- ROE %
- 5.42%
- ROCE %
- 7.41%
- 3.22%
- Debtor Days
- 51
- Inventory Days
- 51
- Payable Days
- 117
- -14
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 3.09x
- 1.21x
- Revenue Growth %
- 14.99%
- Operating Profit Growth %
- 9.56%
- Net Profit Growth %
- -8.53%
- -19.92%
- P/E (x)
- 68.64x
- P/B (x)
- 3.11x
- Dividend Yield %
- 0.00%
- 21.17x
Mar 2025
- EPS (₹)
- 7.97
- Book Value (₹)
- 128.78
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 17.49
- Operating Margin %
- 28.18%
- Net Margin %
- 9.86%
- ROE %
- 6.48%
- ROCE %
- 8.52%
- 4.35%
- Debtor Days
- 53
- Inventory Days
- 73
- Payable Days
- 108
- 19
- Debt to Equity (x)
- 0.31x
- Interest Coverage (x)
- 3.56x
- 1.41x
- Revenue Growth %
- 15.80%
- Operating Profit Growth %
- 23.55%
- Net Profit Growth %
- 49.96%
- 48.59%
- P/E (x)
- 26.55x
- P/B (x)
- 1.64x
- Dividend Yield %
- 0.00%
- 10.73x
Documents
Announcements
- Analysts/Institutional Investor Meet/Con. Call Updates
2026-08-03 - Sakar Healthcare Limited has informed the Exchange about Transcript of Con-Call.
- Copy of Newspaper Publication
2026-08-01 - Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication
Annual Reports
Credit Ratings
Nothing filed yet.
Concalls
Aug 2026
May 2026
Feb 2026